Oral Mucositis among Patients Undergoing Chemotherapy. Oral mucositis (ulcerative) due to antineoplastic therapy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 years and older undergoing chemotherapy for any type of cancer Patient with no history of oral mucositis or other oral conditions that could interfere with study Patients who agree to participate in the study
Exclusion criteria
Exclusion criteria: Patient with known allergies to chamomile and ozonated water Patient who are pregnant or breastfeeding Patient who are unable to comply with study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reducing or prevention of Oral Mucositis among Patients Undergoing Chemotherapy. Timepoint: The patients response is assessed for oral mucositis within two weeks after intervention. Method of measurement: The World Health Organization (WHO) mucositis scale is used to grade the severity of oral mucositis. | — |
Countries
Iraq
Contacts
Collage of Nursing/ University of Baghdad